The global medical device clinical trials market is experiencing remarkable growth, with forecasts predicting an upward trajectory from USD 16.70 billion in 2024 to USD 30.53 billion by 2034. This substantial increase is largely driven by the pervasive rise in chronic diseases, which sets the stage
A recent study on metastatic pancreatic adenocarcinoma (mPDAC) patients reveals significant disparities in care based on race, socioeconomic status, and other social factors, impacting the outcomes and quality of care received. The study, co-authored by Dr. Diamantis Tsilimigras and Dr. Timothy M.
In a groundbreaking study, researchers have uncovered promising evidence suggesting that sulforaphane, a compound found in cruciferous vegetables like broccoli, can play a significant role in preventing lung cancer, particularly among former smokers. As the leading cause of cancer-related deaths,
Alzheimer’s disease, a devastating condition affecting millions, remains a formidable challenge for researchers and clinicians alike. Recent advancements in precision medicine offer a promising frontier in the battle against this neurodegenerative disorder. At the helm of this exciting development i
Innovation thrives at the intersection of regulatory flexibility and robust oversight, especially within the dynamic field of first-in-class drugs. Today, we delve into this critical topic with Ivan Kairatov, a seasoned biopharma expert with extensive experience in research and development. With a
The medical landscape has been witnessing a groundbreaking shift with the advent of novel therapies aimed at tackling some of the most challenging conditions. One such development is the Phase 1/2 clinical trial of Cabaletta Bio's CAR T-cell therapy, rese-cel (resecabtagene autoleucel),
